ESWI activities

ESWI Airborne: Life as a scientist
Listen to the new ESWI podcast series featuring Early Career Scientist and explore the joys and sorrows of establishing a scientific career.
Webinar: Immunisation & Treatment
30 November 2023
Online webinar
ESWI Airborne: Immunisation & Treatment
New ESWI podcast series diving into immunisation & treatment with a line-up of renowned experts in the field of respiratory virus infections.
Burden of acute respiratory virus infections
14 November 2023
Online webinar


ESWI Respiratory Virus Summit 2024
Brussels & online
13th Meeting of the International Society of Pneumonia and Pneumococcal Diseases
Cape Town, South Africa
ISPPD-13 will take place between 17-20 March 2024 in Cape Town (South Africa) at the International Convention Centre.
World Vaccine Congress Washington 2024
Washington, D.C.
The World Vaccine Congress Washington will bring together industry experts across the entire vaccine landscape.
5th International Symposium on Neglected Influenza Viruses
Lexington, Kentucky, USA
The meeting will explore the latest research on surveillance and disease investigation, virus transmission and control, clinical and experimental virology, plus emerging issues and new developments related to other non-human influenza viruses.
Barcelona, Spain
The 34th annual congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) will take place between the 27th and the 30th of April 2024 in Barcelona.
CISTM19 Theme: “Expanding the Horizons of Travel Medicine”
New Orleans
The ISTM International Congresses offer travel medicine specialists the opportunity to learn the most up to date information in the field.

Education hub

Scientific Papers
Influenza vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Society of Cardiology, the Portuguese Society of Diabetology, the Portuguese Society of Infectious Disea
Influenza affects millions of people worldwide each year and can lead to severe complications, hospitalizations, and even death, especially among vulnerable populations such as older adults and those with chronic medical conditions.
Evaluation of the effectiveness and impact of Nirsevimab in Galicia
The purpose of NIRSE-GAL is to evaluate the impact of the inclusion of nirsevimab in the Galician immunisation schedule on the prevention of Respiratory Syncytial Respiratory Syncytial Virus (RSV) infections in children.
Perception of government performance during COVID-19 not linked to death rate.
People living in the United States are more likely to report that their government handled the COVID-19 pandemic ‘well’ than any other G7 nation despite having the highest death rate, according to a new report from the Global Listening Project.
Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohort
The protection of fourth dose mRNA vaccination against SARS-CoV-2 is relevant to current global policy decisions regarding ongoing booster roll-out.

ESWI networks & communities

Influenza Diabetes Community

The Influenza Diabetes Community (IDC) unites scientists, healthcare professionals, patient -and other stakeholder organisations to discuss, share best practices and to network with the objective to raise awareness of the burden of influenza, Covid-19 and RSV in people living with diabetes.

Early Career Scientists Network

Some of the best and most innovative ideas come from early career scientists, they are the future of the influenza field. For this reason, ESWI has been actively encouraging the careers of early career scientists for many years.